Zdrowie i gospodarka · 14/11/2014
FDA Amends Blood Products Advisory Committee Meeting Notice
The Food and Drug Administration (FDA) is updating the meeting notice of the Blood Products Advisory Committee, originally announced on October 22, 2014, to reflect a change in the agenda.